Cancer Research Meeting Calendar  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, S.
Right arrow Articles by Furukawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, S.
Right arrow Articles by Furukawa, K.
[Cancer Research 61, 4244-4252, May 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Ganglioside GD2 in Small Cell Lung Cancer Cell Lines

Enhancement of Cell Proliferation and Mediation of Apoptosis1

Shoko Yoshida, Satoshi Fukumoto, Haruhiko Kawaguchi, Shigeki Sato, Ryuzo Ueda and Koichi Furukawa2

Department of Biochemistry II, Nagoya University School of Medicine, Nagoya 466-0065 [S. Y., S. F., K. F.]; Department of Internal Medicine II, Nagoya City University School of Medicine, Nagoya 467-8601 [S. Y., H. K., S. S., R. U.]; and Department of Pediatric Dentistry, Nagasaki University School of Dentistry, Nagasaki 852-8102 [S. F.], Japan

Expression levels of gangliosides and glycosyltransferase genes responsible for their syntheses in human lung cancer cell lines and a normal bronchial epithelial cell line were analyzed. Both non-small cell lung cancers and small cell lung cancers (SCLCs) mainly expressed GM2 and GM1, whereas only SCLCs expressed b-series gangliosides, such as GD2, GD1b, and GT1b. Accordingly, many SCLC cell lines showed up-regulation of the GD3 synthase gene. Consequently, we introduced GD3 synthase cDNA into a SCLC line with low expression of b-series gangliosides and analyzed the effects of newly expressed gangliosides on tumor phenotypes. The transfectant cells expressing high levels of GD2 and GD3 exhibited markedly increased growth rates and strongly enhanced invasion activities. Addition of anti-GD2 monoclonal antibodies into the culture medium of these cells resulted in the marked growth suppression of GD2-expressing cell lines with reduced activation levels of mitogen-activated protein kinases but not of nonexpressants, suggesting that GD2 plays important roles in cell proliferation. Moreover, GD2-expressing cells treated with anti-GD2 antibodies showed features of apoptotic cell death at 30 min after addition of antibodies, i.e., shrinkage of cytoplasm, binding of Annexin V, and staining with propidium iodide, followed by DNA fragmentation. This GD2-mediated apoptosis was associated with caspase-3 activation and partly inhibited by a caspase inhibitor, z-Val-Ala-Asp-fluoromethyl ketone. The finding that anti-GD2 antibodies suppressed the cell growth and induced apoptosis of SCLC cells strongly suggested the usefulness of GD2 as a target for the therapy of disastrous cancer, although the precise mechanisms for apoptosis remain to be clarified.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. Alvarez-Rueda, S. Leprieur, B. Clemenceau, S. Supiot, V. Sebille-Rivain, A. Faivre-Chauvet, F. Davodeau, F. Paris, J. Barbet, J. Aubry, et al.
Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen
Clin. Cancer Res., September 15, 2007; 13(18): 5613s - 5620s.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Raval, S. Biswas, P. Rayman, K. Biswas, G. Sa, S. Ghosh, M. Thornton, C. Hilston, T. Das, R. Bukowski, et al.
TNF-{alpha} Induction of GM2 Expression on Renal Cell Carcinomas Promotes T Cell Dysfunction
J. Immunol., May 15, 2007; 178(10): 6642 - 6652.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Tokuda, Q. Zhang, S. Yoshida, S. Kusunoki, T. Urano, K. Furukawa, and K. Furukawa
Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines
Glycobiology, October 1, 2006; 16(10): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. A. Crespo, X. Sun, J. G. Cripps, and R. Fernandez-Botran
The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses
J. Leukoc. Biol., March 1, 2006; 79(3): 586 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Aixinjueluo, K. Furukawa, Q. Zhang, K. Hamamura, N. Tokuda, S. Yoshida, R. Ueda, and K. Furukawa
Mechanisms for the Apoptosis of Small Cell Lung Cancer Cells Induced by Anti-GD2 Monoclonal Antibodies: ROLES OF ANOIKIS
J. Biol. Chem., August 19, 2005; 280(33): 29828 - 29836.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Hamamura, K. Furukawa, T. Hayashi, T. Hattori, J. Nakano, H. Nakashima, T. Okuda, H. Mizutani, H. Hattori, M. Ueda, et al.
Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells
PNAS, August 2, 2005; 102(31): 11041 - 11046.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. W. Retter, J. C. Johnson, D. W. Peckham, J. E. Bannink, C. S. Bangur, K. Dresser, F. Cai, T. M. Foy, N. A. Fanger, G. R. Fanger, et al.
Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts
Cancer Res., July 15, 2005; 65(14): 6425 - 6434.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Monzavi-Karbassi, C. Artaud, F. Jousheghany, L. Hennings, J. Carcel-Trullols, S. Shaaf, S. Korourian, and T. Kieber-Emmons
Reduction of Spontaneous Metastases through Induction of Carbohydrate Cross-Reactive Apoptotic Antibodies
J. Immunol., June 1, 2005; 174(11): 7057 - 7065.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. L. Kiechle
Glycosphingolipids in Health and Disease
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Wang, P. Sun, and A. S. Paller
Inhibition of Integrin-linked Kinase/Protein Kinase B/Akt Signaling. MECHANISM FOR GANGLIOSIDE-INDUCED APOPTOSIS
J. Biol. Chem., November 21, 2001; 276(48): 44504 - 44511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.